Glioma: all 1,425 studies
Page 11 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Terameprocol in Treating Patients With Recurrent High Grade GliomaCompletedNCT02575794Phase 1
- CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma PatientsWithdrawnNCT02575261Phase 1/2
- Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade GliomaCompletedNCT02567539Not applicable
- CTCs for High Grade GliomaCompletedNCT02558335
- Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II GliomaCompletedNCT02549833Phase 1
- Fluorescein vs. iMRI in Resection of Malignant High Grade GliomaWithdrawnNCT02540135Not applicable
- 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary GliomasStatus unknownNCT02520882Early Phase 1
- Non Invasive Measurements of Intracranial Pressure in Patients With Malignant GliomaCompletedNCT02520492Not applicable
- 11C-Methionine PET as Prognostic Marker of GliomasCompletedNCT02518061
- Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant GliomaCompletedNCT02507583Phase 1
- Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade GliomasTerminatedNCT02507232Early Phase 1
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsCompletedNCT02502708Phase 1
- Topotecan in Glioma Undergoing A Clinically-Indicated Surgical ResectionTerminatedNCT02500459Early Phase 1
- Metformin And Chloroquine in IDH1/2-mutated Solid TumorsCompletedNCT02496741Phase 1/2
- Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma TumoursTerminatedNCT02491827
- Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade GliomaTerminatedNCT02481960Phase 1/2
- Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their PartnersActive, not recruitingNCT02481349Not applicable
- Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 MutationCompletedNCT02481154Phase 1
- Search of Protein Biomarkers in Order to Achieve a Molecular Classification of GliomasCompletedNCT02473484
- Fluorescence Spectroscopy Guided SurgeryCompletedNCT02473380Phase 1
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsCompletedNCT02457845Phase 1
- Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV GliomasCompletedNCT02454634Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine GliomaCompletedNCT02420613Phase 1
- Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade GliomasStatus unknownNCT02416999Not applicable
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsCompletedNCT02415153Phase 1
- Radionecrosis and FDG PETStatus unknownNCT02391246
- Clinical Development of Cancer-Specific MRS Biomarkers in Malignant GliomasCompletedNCT02388659
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation TherapyTerminatedNCT02375334
- FDOPA-PET/MRI for the Pre-operative Evaluation of GliomasTerminatedNCT02371031Phase 1
- Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe AstheniaStatus unknownNCT02363075Phase 3
- Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaActive, not recruitingNCT02359565Phase 1
- Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic GliomaStatus unknownNCT02345824Phase 1
- A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 MutationStatus unknownNCT02333513Not applicable
- CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFRStatus unknownNCT02331693Phase 1
- 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer PatientsStatus unknownNCT02327442
- Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)TerminatedNCT02305056Phase 1
- Effects of Exercise on Cognitive Function in Glioma PatientsCompletedNCT02303938Not applicable
- D2C7 for Adult Patients With Recurrent Malignant GliomaCompletedNCT02303678Phase 1
- Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)CompletedNCT02300532
- Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade GliomaCompletedNCT02300506
- Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade GliomaCompletedNCT02286531Not applicable
- Glioma Modified Atkins-based Diet in Patients With GlioblastomaCompletedNCT02286167Not applicable
- Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesTerminatedNCT02279992Early Phase 1
- Topotecan Using Convection-Enhanced Delivery (CED) in High Grade GliomaCompletedNCT02278510Early Phase 1
- Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)CompletedNCT02272270Phase 1
- Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade GliomasCompletedNCT02263105Phase 2
- Confocal Laser Endomicroscopy for Brain TumorsTerminatedNCT02240758Phase 1
- HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)Status unknownNCT02239952Not applicable
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompletedNCT02238496Phase 1
- Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing SurgeryCompletedNCT02234297Phase 1
- Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) EradicationStatus unknownNCT02233049Phase 2
- Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer TreatmentCompletedNCT02221986Not applicable
- Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade GliomaCompletedNCT02197637Phase 2
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- ALA-induced PpIX Fluorescence During Brain Tumor ResectionActive, not recruitingNCT02191488Phase 1
- Rotating Frame Relaxation and Diffusion Weighted Imaging of Human GliomasCompletedNCT02186262
- Fluorescence and Glioma HeterogeneityCompletedNCT02155452
- Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal SurgeryStatus unknownNCT02122042Phase 1
- 5-ALA in Recurrent GliomaStatus unknownNCT02119338Not applicable
- Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCompletedNCT02115074Phase 1
- A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in GliomasActive, not recruitingNCT02104310
- Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaCompletedNCT02101905Phase 1
- Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade GliomaCompletedNCT02099487Phase 2
- Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.Status unknownNCT02078401
- Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) "CONDUCTOME"TerminatedNCT02077504Phase 1
- Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationCompletedNCT02073994Phase 1
- Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological CharacteristicsStatus unknownNCT02047058
- Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade GliomasCompletedNCT02041611Not applicable
- Image Guided Reirradiation of High-grade GliomaTerminatedNCT02025231Phase 1/2
- Prognostic Awareness and Patient-Physician Communication in Malignant GliomaCompletedNCT02023346
- Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)CompletedNCT02022800Not applicable
- Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade GliomaCompletedNCT02022644Phase 1
- 18F-DOPA-PET in Planning Surgery in Patients with GliomasCompletedNCT02020720Early Phase 1
- Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent GlioblastomaCompletedNCT02010606Phase 1
- Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1
- Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaTerminatedNCT01989052Phase 1
- ANG1005 in Patients With Recurrent High-Grade GliomaCompletedNCT01967810Phase 2
- C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progressionWithdrawnNCT01961934Phase 2/3
- Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureTerminatedNCT01954030Phase 1
- Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma PatientsWithdrawnNCT01952886Phase 2
- Anti PD1 Antibody in Diffuse Intrinsic Pontine GliomaStatus unknownNCT01952769Phase 1/2
- STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainCompletedNCT01904123Phase 1
- Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain TumorsTerminatedNCT01902771Phase 1
- A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade GliomaCompletedNCT01891747Phase 1
- Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young AdultsTerminatedNCT01887522Phase 2
- Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young AdultsCompletedNCT01884922Phase 1
- Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in ChildrenCompletedNCT01878266Not applicable
- FMISO-PET in Brain Tumors and SCS EffectTerminatedNCT01868906Phase 2
- A Phase I Study of Mebendazole for the Treatment of Pediatric GliomasActive, not recruitingNCT01837862Phase 1/2
- Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma PatientsCompletedNCT01836536Not applicable
- Combined Cytotoxic and Immune-Stimulatory Therapy for GliomaCompletedNCT01811992Phase 1
- Dendritic Cell (DC) Vaccine for Malignant Glioma and GlioblastomaCompletedNCT01808820Phase 1
- 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of GliomaStatus unknownNCT01801371Early Phase 1
- Dendritic Cell Vaccine With Imiquimod for Patients With Malignant GliomaCompletedNCT01792505Phase 1
- A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid TumoursCompletedNCT01792310Phase 1/2
- Open-Label Study of I-131-CLR1404 in Subjects With Recurrent GliomaWithdrawnNCT01778088Phase 2
- A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade GliomasStatus unknownNCT01765088Phase 3